Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 95 entries
Sorted by: Best Match Show Resources per page
Inhaler Use in Hospitalized Patients with Chronic Obstructive Pulmonary Disease or Asthma: Assessment of Wasted Doses.

Hospital pharmacy

Sakaan S, Ulrich D, Luo J, Finch CK, Self TH.
PMID: 26405325
Hosp Pharm. 2015 May;50(5):386-90. doi: 10.1310/hpj5005-386.

BACKGROUND: Hospitalized patients with chronic obstructive pulmonary disease (COPD) or asthma routinely have inhaled medications ordered for acute and maintenance therapy. Treatment may be administered via metered-dose inhaler (MDI) or dry-powder inhaler (DPI). These products must be appropriately labeled...

Cite
Sakaan S, Ulrich D, Luo J, et al. Inhaler Use in Hospitalized Patients with Chronic Obstructive Pulmonary Disease or Asthma: Assessment of Wasted Doses. Hosp Pharm. 2015;50(5):386-90doi: 10.1310/hpj5005-386.
Sakaan, S., Ulrich, D., Luo, J., Finch, C. K., & Self, T. H. (2015). Inhaler Use in Hospitalized Patients with Chronic Obstructive Pulmonary Disease or Asthma: Assessment of Wasted Doses. Hospital pharmacy, 50(5), 386-90. https://doi.org/10.1310/hpj5005-386
Sakaan, Sami, et al. "Inhaler Use in Hospitalized Patients with Chronic Obstructive Pulmonary Disease or Asthma: Assessment of Wasted Doses." Hospital pharmacy vol. 50,5 (2015): 386-90. doi: https://doi.org/10.1310/hpj5005-386
Sakaan S, Ulrich D, Luo J, Finch CK, Self TH. Inhaler Use in Hospitalized Patients with Chronic Obstructive Pulmonary Disease or Asthma: Assessment of Wasted Doses. Hosp Pharm. 2015 May;50(5):386-90. doi: 10.1310/hpj5005-386. PMID: 26405325; PMCID: PMC4567205.
Copy Download .nbib Format: NLM
Noncardiogenic Pulmonary Edema after Amlodipine Overdose without Refractory Hypotension and Bradycardia.

Case reports in emergency medicine

Hedaiaty M, Eizadi-Mood N, Sabzghabaee AM.
PMID: 26075111
Case Rep Emerg Med. 2015;2015:546012. doi: 10.1155/2015/546012. Epub 2015 May 05.

Amlodipine overdose can be life-threatening when manifesting as noncardiogenic pulmonary edema. Treatment remains challenging. We describe a case of noncardiogenic pulmonary edema without refractory hypotension and bradycardia after ingestion of 500 milligram amlodipine with suicidal intent. Mechanical ventilation, dexamethasone,...

Cite
Hedaiaty M, Eizadi-Mood N, Sabzghabaee AM. Noncardiogenic Pulmonary Edema after Amlodipine Overdose without Refractory Hypotension and Bradycardia. Case Rep Emerg Med. 2015;2015:546012doi: 10.1155/2015/546012.
Hedaiaty, M., Eizadi-Mood, N., & Sabzghabaee, A. M. (2015). Noncardiogenic Pulmonary Edema after Amlodipine Overdose without Refractory Hypotension and Bradycardia. Case reports in emergency medicine, 2015546012. https://doi.org/10.1155/2015/546012
Hedaiaty, M, et al. "Noncardiogenic Pulmonary Edema after Amlodipine Overdose without Refractory Hypotension and Bradycardia." Case reports in emergency medicine vol. 2015 (2015): 546012. doi: https://doi.org/10.1155/2015/546012
Hedaiaty M, Eizadi-Mood N, Sabzghabaee AM. Noncardiogenic Pulmonary Edema after Amlodipine Overdose without Refractory Hypotension and Bradycardia. Case Rep Emerg Med. 2015;2015:546012. doi: 10.1155/2015/546012. Epub 2015 May 05. PMID: 26075111; PMCID: PMC4436504.
Copy Download .nbib Format: NLM
"Don't Believe Your Eyes" Ipratropium Induced Mydriasis: A Case Report and Review of the Literature.

General medicine (Los Angeles, Calif.)

Pennington KM, St Louis EK.
PMID: 27683661
Gen Med (Los Angel). 2016 Jun;4(3). doi: 10.4172/2327-5146.1000255. Epub 2016 Jun 29.

Unilateral fixed mydriasis can be an ominous sign; however in many cases, it is benign and represents pharmacologic mediated action on the iris dilator or sphincter. Differentiation between pharmacologic mediated anisocoria and physiologic anisocoria can be challenging but may...

Cite
Pennington KM, St Louis EK. "Don't Believe Your Eyes" Ipratropium Induced Mydriasis: A Case Report and Review of the Literature. Gen Med (Los Angel). 2016;4(3)doi: 10.4172/2327-5146.1000255.
Pennington, K. M., & St Louis, E. K. (2016). "Don't Believe Your Eyes" Ipratropium Induced Mydriasis: A Case Report and Review of the Literature. General medicine (Los Angeles, Calif.), 4(3), . https://doi.org/10.4172/2327-5146.1000255
Pennington, Kelly M, and St Louis, Erik K. ""Don't Believe Your Eyes" Ipratropium Induced Mydriasis: A Case Report and Review of the Literature." General medicine (Los Angeles, Calif.) vol. 4,3 (2016). doi: https://doi.org/10.4172/2327-5146.1000255
Pennington KM, St Louis EK. "Don't Believe Your Eyes" Ipratropium Induced Mydriasis: A Case Report and Review of the Literature. Gen Med (Los Angel). 2016 Jun;4(3). doi: 10.4172/2327-5146.1000255. Epub 2016 Jun 29. PMID: 27683661; PMCID: PMC5036352.
Copy Download .nbib Format: NLM
Gateways to clinical trials.

Methods and findings in experimental and clinical pharmacology

Bayés M, Rabasseda X, Prous JR.
PMID: 16082422
Methods Find Exp Clin Pharmacol. 2005 Jun;27(5):331-72.

Gateways to Clinical Trials is a guide to the most recent clinical trials in current literature and congresses. The data in the following tables have been retrieved from the Clinical Trials Knowledge Area of Prous Science Integrity, the drug...

Cite
Bayés M, Rabasseda X, Prous JR. Gateways to clinical trials. Methods Find Exp Clin Pharmacol. 2005;27(5):331-72
Bayés, M., Rabasseda, X., & Prous, J. R. (2005). Gateways to clinical trials. Methods and findings in experimental and clinical pharmacology, 27(5), 331-72.
Bayés, M, et al. "Gateways to clinical trials." Methods and findings in experimental and clinical pharmacology vol. 27,5 (2005): 331-72.
Bayés M, Rabasseda X, Prous JR. Gateways to clinical trials. Methods Find Exp Clin Pharmacol. 2005 Jun;27(5):331-72. PMID: 16082422.
Copy Download .nbib Format: NLM
Radioreceptor assays of ipratropium bromide in plasma and urine.

Journal of pharmaceutical and biomedical analysis

Ensing K, Pol M, De Zeeuw RA.
PMID: 16867389
J Pharm Biomed Anal. 1988;6(5):433-9. doi: 10.1016/0731-7085(88)80010-4.

Ipratropium bromide (Ipbr) is a frequently used quaternary anticholinergic administered by inhalation in the treatment of chronic obstructive lung diseases. Hardly any pharmacokinetic data are available, which can be useful in the optimisation of anticholinergic therapies. Hence, a radioreceptor...

Cite
Ensing K, Pol M, De Zeeuw RA. Radioreceptor assays of ipratropium bromide in plasma and urine. J Pharm Biomed Anal. 1988;6(5):433-9doi: 10.1016/0731-7085(88)80010-4.
Ensing, K., Pol, M., & De Zeeuw, R. A. (1988). Radioreceptor assays of ipratropium bromide in plasma and urine. Journal of pharmaceutical and biomedical analysis, 6(5), 433-9. https://doi.org/10.1016/0731-7085(88)80010-4
Ensing, K, et al. "Radioreceptor assays of ipratropium bromide in plasma and urine." Journal of pharmaceutical and biomedical analysis vol. 6,5 (1988): 433-9. doi: https://doi.org/10.1016/0731-7085(88)80010-4
Ensing K, Pol M, De Zeeuw RA. Radioreceptor assays of ipratropium bromide in plasma and urine. J Pharm Biomed Anal. 1988;6(5):433-9. doi: 10.1016/0731-7085(88)80010-4. PMID: 16867389.
Copy Download .nbib Format: NLM
A pharmacovigilance study on patients of bronchial asthma in a teaching hospital.

Journal of pharmacy & bioallied sciences

Jamali AN, Aqil M, Alam MS, Pillai KK, Kapur P.
PMID: 21180467
J Pharm Bioallied Sci. 2010 Oct;2(4):333-6. doi: 10.4103/0975-7406.72135.

OBJECTIVE: The present study was conducted to monitor adverse drug reactions in patients of bronchial asthma in outpatient department and inpatient department of a university teaching hospital in South Delhi.MATERIALS AND METHODS: About 200 patients irrespective of age and...

Cite
Jamali AN, Aqil M, Alam MS, et al. A pharmacovigilance study on patients of bronchial asthma in a teaching hospital. J Pharm Bioallied Sci. 2010;2(4):333-6doi: 10.4103/0975-7406.72135.
Jamali, A. N., Aqil, M., Alam, M. S., Pillai, K. K., & Kapur, P. (2010). A pharmacovigilance study on patients of bronchial asthma in a teaching hospital. Journal of pharmacy & bioallied sciences, 2(4), 333-6. https://doi.org/10.4103/0975-7406.72135
Jamali, A N, et al. "A pharmacovigilance study on patients of bronchial asthma in a teaching hospital." Journal of pharmacy & bioallied sciences vol. 2,4 (2010): 333-6. doi: https://doi.org/10.4103/0975-7406.72135
Jamali AN, Aqil M, Alam MS, Pillai KK, Kapur P. A pharmacovigilance study on patients of bronchial asthma in a teaching hospital. J Pharm Bioallied Sci. 2010 Oct;2(4):333-6. doi: 10.4103/0975-7406.72135. PMID: 21180467; PMCID: PMC2996060.
Copy Download .nbib Format: NLM
Etiology. Recent use of ipratropium bromide increased risk for cardiovascular events in chronic obstructive pulmonary disease.

Annals of internal medicine

[No authors listed]
PMID: 20643981
Ann Intern Med. 2010 Jul 20;153(2):JC1-3. doi: 10.7326/0003-4819-153-2-201007200-02003.

No abstract available.

Cite
Etiology. Recent use of ipratropium bromide increased risk for cardiovascular events in chronic obstructive pulmonary disease. Ann Intern Med. 2010;153(2):JC1-3doi: 10.7326/0003-4819-153-2-201007200-02003.
(2010). Etiology. Recent use of ipratropium bromide increased risk for cardiovascular events in chronic obstructive pulmonary disease. Annals of internal medicine, 153(2), JC1-3. https://doi.org/10.7326/0003-4819-153-2-201007200-02003
"Etiology. Recent use of ipratropium bromide increased risk for cardiovascular events in chronic obstructive pulmonary disease." Annals of internal medicine vol. 153,2 (2010): JC1-3. doi: https://doi.org/10.7326/0003-4819-153-2-201007200-02003
Etiology. Recent use of ipratropium bromide increased risk for cardiovascular events in chronic obstructive pulmonary disease. Ann Intern Med. 2010 Jul 20;153(2):JC1-3. doi: 10.7326/0003-4819-153-2-201007200-02003. PMID: 20643981.
Copy Download .nbib Format: NLM
A successful treatment strategy for clozapine-induced parotid swelling: a clinical case and systematic review.

Therapeutic advances in psychopharmacology

Immadisetty V, Agrawal P.
PMID: 23983982
Ther Adv Psychopharmacol. 2012 Dec;2(6):235-9. doi: 10.1177/2045125312455187.

Parotid gland swelling is a less frequently reported side effect of clozapine and has no licensed treatment. A 58-year-old man treated with clozapine for treatment-resistant schizophrenia developed bilateral painful parotid swellings and hypersalivation. Initial trials of dose alteration and...

Cite
Immadisetty V, Agrawal P. A successful treatment strategy for clozapine-induced parotid swelling: a clinical case and systematic review. Ther Adv Psychopharmacol. 2012;2(6):235-9doi: 10.1177/2045125312455187.
Immadisetty, V., & Agrawal, P. (2012). A successful treatment strategy for clozapine-induced parotid swelling: a clinical case and systematic review. Therapeutic advances in psychopharmacology, 2(6), 235-9. https://doi.org/10.1177/2045125312455187
Immadisetty, Vyasa, and Agrawal, Pradeep. "A successful treatment strategy for clozapine-induced parotid swelling: a clinical case and systematic review." Therapeutic advances in psychopharmacology vol. 2,6 (2012): 235-9. doi: https://doi.org/10.1177/2045125312455187
Immadisetty V, Agrawal P. A successful treatment strategy for clozapine-induced parotid swelling: a clinical case and systematic review. Ther Adv Psychopharmacol. 2012 Dec;2(6):235-9. doi: 10.1177/2045125312455187. PMID: 23983982; PMCID: PMC3736957.
Copy Download .nbib Format: NLM
Does implementation of a paediatric asthma clinical practice guideline worksheet change clinical practice?.

International journal of emergency medicine

Gildenhuys J, Lee M, Isbister GK.
PMID: 19390915
Int J Emerg Med. 2009 Apr;2(1):33-9. doi: 10.1007/s12245-008-0063-x. Epub 2008 Nov 18.

BACKGROUND: Despite the development of evidence-based practice guidelines in many countries for asthma treatment in children, there is limited evidence that using such guidelines improves patient care.AIMS: Our aim was to evaluate whether the implementation of an evidence-based asthma...

Cite
Gildenhuys J, Lee M, Isbister GK. Does implementation of a paediatric asthma clinical practice guideline worksheet change clinical practice?. Int J Emerg Med. 2008;2(1):33-9doi: 10.1007/s12245-008-0063-x.
Gildenhuys, J., Lee, M., & Isbister, G. K. (2009). Does implementation of a paediatric asthma clinical practice guideline worksheet change clinical practice?. International journal of emergency medicine, 2(1), 33-9. https://doi.org/10.1007/s12245-008-0063-x
Gildenhuys, Johann, et al. "Does implementation of a paediatric asthma clinical practice guideline worksheet change clinical practice?." International journal of emergency medicine vol. 2,1 (2009): 33-9. doi: https://doi.org/10.1007/s12245-008-0063-x
Gildenhuys J, Lee M, Isbister GK. Does implementation of a paediatric asthma clinical practice guideline worksheet change clinical practice?. Int J Emerg Med. 2009 Apr;2(1):33-9. doi: 10.1007/s12245-008-0063-x. Epub 2008 Nov 18. PMID: 19390915; PMCID: PMC2672973.
Copy Download .nbib Format: NLM
Management of allergic rhinitis.

The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG

Sausen VO, Marks KE, Sausen KP, Self TH.
PMID: 23118635
J Pediatr Pharmacol Ther. 2005 Jul;10(3):159-73. doi: 10.5863/1551-6776-10.3.159.

Allergic rhinitis is the most common chronic childhood disease. Reduced quality of life is frequently caused by this IgE-mediated disease, including sleep disturbance with subsequent decreased school performance. Asthma and exercise-induced bronchospasm are commonly seen concurrently with allergic rhinitis,...

Cite
Sausen VO, Marks KE, Sausen KP, et al. Management of allergic rhinitis. J Pediatr Pharmacol Ther. 2005;10(3):159-73doi: 10.5863/1551-6776-10.3.159.
Sausen, V. O., Marks, K. E., Sausen, K. P., & Self, T. H. (2005). Management of allergic rhinitis. The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG, 10(3), 159-73. https://doi.org/10.5863/1551-6776-10.3.159
Sausen, Verra O, et al. "Management of allergic rhinitis." The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG vol. 10,3 (2005): 159-73. doi: https://doi.org/10.5863/1551-6776-10.3.159
Sausen VO, Marks KE, Sausen KP, Self TH. Management of allergic rhinitis. J Pediatr Pharmacol Ther. 2005 Jul;10(3):159-73. doi: 10.5863/1551-6776-10.3.159. PMID: 23118635; PMCID: PMC3468067.
Copy Download .nbib Format: NLM
Response of the adrenergic system after provoked bronchoconstriction in patients with bronchial asthma.

Acta informatica medica : AIM : journal of the Society for Medical Informatics of Bosnia & Herzegovina : casopis Drustva za medicinsku informatiku BiH

Islami H, Ilazi A, Gashi N, Mustafa L, Maloku H, Jashanica A.
PMID: 24825935
Acta Inform Med. 2014 Apr;22(2):107-10. doi: 10.5455/aim.2014.22.107-110.

OBJECTIVE: In this paper, effect of the Tolazoline as antagonist of the alpha-2 adrenergic receptors in patients with bronchial asthma and chronic obstructive bronchitis was studied, and also the effect of stimulation with Hexoprenaline of beta-2 adrenergic receptor after...

Cite
Islami H, Ilazi A, Gashi N, et al. Response of the adrenergic system after provoked bronchoconstriction in patients with bronchial asthma. Acta Inform Med. 2014;22(2):107-10doi: 10.5455/aim.2014.22.107-110.
Islami, H., Ilazi, A., Gashi, N., Mustafa, L., Maloku, H., & Jashanica, A. (2014). Response of the adrenergic system after provoked bronchoconstriction in patients with bronchial asthma. Acta informatica medica : AIM : journal of the Society for Medical Informatics of Bosnia & Herzegovina : casopis Drustva za medicinsku informatiku BiH, 22(2), 107-10. https://doi.org/10.5455/aim.2014.22.107-110
Islami, Hilmi, et al. "Response of the adrenergic system after provoked bronchoconstriction in patients with bronchial asthma." Acta informatica medica : AIM : journal of the Society for Medical Informatics of Bosnia & Herzegovina : casopis Drustva za medicinsku informatiku BiH vol. 22,2 (2014): 107-10. doi: https://doi.org/10.5455/aim.2014.22.107-110
Islami H, Ilazi A, Gashi N, Mustafa L, Maloku H, Jashanica A. Response of the adrenergic system after provoked bronchoconstriction in patients with bronchial asthma. Acta Inform Med. 2014 Apr;22(2):107-10. doi: 10.5455/aim.2014.22.107-110. PMID: 24825935; PMCID: PMC4008033.
Copy Download .nbib Format: NLM
Ipratropium bromide: analytical methods.

Profiles of drug substances, excipients, and related methodology

H Abdine F Belal H, A Al-Badr A.
PMID: 22469542
Profiles Drug Subst Excip Relat Methodol. 2003;30:101-16. doi: 10.1016/S0099-5428(03)30005-X.

No abstract available.

Cite
H Abdine F Belal H, A Al-Badr A. Ipratropium bromide: analytical methods. Profiles Drug Subst Excip Relat Methodol. 2003;30:101-16doi: 10.1016/S0099-5428(03)30005-X.
H Abdine F Belal, H., & A Al-Badr, A. (2003). Ipratropium bromide: analytical methods. Profiles of drug substances, excipients, and related methodology, 30101-16. https://doi.org/10.1016/S0099-5428(03)30005-X
H Abdine F Belal, Heba, and A Al-Badr, Abdullah. "Ipratropium bromide: analytical methods." Profiles of drug substances, excipients, and related methodology vol. 30 (2003): 101-16. doi: https://doi.org/10.1016/S0099-5428(03)30005-X
H Abdine F Belal H, A Al-Badr A. Ipratropium bromide: analytical methods. Profiles Drug Subst Excip Relat Methodol. 2003;30:101-16. doi: 10.1016/S0099-5428(03)30005-X. PMID: 22469542.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 95 entries